stockrowPerrigo Company plc
PRGO Healthcare Drug Manufacturers Specialty & Generic
Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024.
- Revenue
- −5.24%
- EPS
- −494.6%
- Free cash flow
- +138.5%
- Total debt
- −9.62%
Quarter to September 2026, against a year earlier
Follow PRGO
Alert me
Perrigo Company plc (PRGO) Gross margin
Perrigo Company plc's gross margin over the twelve months to 30 September 2026 was 32.3%, down 2.8 percentage points from fiscal 2025 (35.1%). Over the past ten years it has ranged from 32.7% (fiscal 2022) to 41.0% (fiscal 2015); the current reading is higher than 25% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 53.5% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 35.1% | (0.13) |
| FY2024 | 35.3% | (0.82) |
| FY2023 | 36.1% | 3.40 |
| FY2022 | 32.7% | (1.53) |
| FY2021 | 34.2% | (2.35) |
| FY2020 | 36.6% | (0.48) |
| FY2019 | 37.1% | (1.66) |
| FY2018 | 38.7% | (1.31) |
| FY2017 | 40.0% | 1.16 |
| FY2016 | 38.9% | (2.13) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 32.5% | 1.76 |
| Jun 2026 | 30.7% | (2.89) |
| Mar 2026 | 33.6% | 0.94 |
| Dec 2025 | 32.6% | (3.50) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. compare | 97.9% |
| XERS Xeris Biopharma Holdings, Inc. compare | 87.4% |
| ANIP ANI Pharmaceuticals, Inc. compare | 61.1% |
| TRLV Trulieve Cannabis Corp. compare | 60.6% |
| PBH Prestige Consumer Healthcare Inc. compare | 52.5% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 44.4% |
| ALVO Alvotech compare | 42.7% |
| PRGO Perrigo Company plc | 32.3% |
| RGC Regencell Bioscience Holdings Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on PRGO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement